Lachlan Brown
Stock Analyst at Rothschild & Co
(1.61)
# 3,514
Out of 5,240 analysts
14
Total ratings
45.45%
Success rate
-2.28%
Average return
Main Sectors:
Stocks Rated by Lachlan Brown
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPSC SPS Commerce | Downgrades: Neutral | $100 → $60 | $49.91 | +20.22% | 2 | Apr 16, 2026 | |
| DSGX The Descartes Systems Group | Upgrades: Buy | $100 → $90 | $66.31 | +35.73% | 2 | Apr 16, 2026 | |
| EPRX Eupraxia Pharmaceuticals | Initiates: Outperform | n/a | $7.55 | - | 1 | Mar 23, 2026 | |
| VRDN Viridian Therapeutics | Initiates: Outperform | n/a | $17.04 | - | 1 | Dec 3, 2025 | |
| MANH Manhattan Associates | Downgrades: Neutral | $270 → $200 | $125.56 | +59.29% | 2 | Jun 10, 2025 | |
| HROW Harrow | Initiates: Outperform | n/a | $29.83 | - | 1 | Jun 10, 2025 | |
| KLRS Kalaris Therapeutics | Initiates: Outperform | n/a | $4.86 | - | 1 | Apr 8, 2025 | |
| OCUL Ocular Therapeutix | Initiates: Outperform | n/a | $9.24 | - | 1 | Apr 8, 2025 | |
| SNPS Synopsys | Initiates: Buy | $600 | $509.28 | +17.81% | 1 | Jan 13, 2025 | |
| CDNS Cadence Design Systems | Initiates: Buy | $350 | $354.55 | -1.28% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $41.03 | - | 1 | Oct 16, 2024 |
SPS Commerce
Apr 16, 2026
Downgrades: Neutral
Price Target: $100 → $60
Current: $49.91
Upside: +20.22%
The Descartes Systems Group
Apr 16, 2026
Upgrades: Buy
Price Target: $100 → $90
Current: $66.31
Upside: +35.73%
Eupraxia Pharmaceuticals
Mar 23, 2026
Initiates: Outperform
Price Target: n/a
Current: $7.55
Upside: -
Viridian Therapeutics
Dec 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $17.04
Upside: -
Manhattan Associates
Jun 10, 2025
Downgrades: Neutral
Price Target: $270 → $200
Current: $125.56
Upside: +59.29%
Harrow
Jun 10, 2025
Initiates: Outperform
Price Target: n/a
Current: $29.83
Upside: -
Kalaris Therapeutics
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $4.86
Upside: -
Ocular Therapeutix
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $9.24
Upside: -
Synopsys
Jan 13, 2025
Initiates: Buy
Price Target: $600
Current: $509.28
Upside: +17.81%
Cadence Design Systems
Jan 13, 2025
Initiates: Buy
Price Target: $350
Current: $354.55
Upside: -1.28%
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $41.03
Upside: -